A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers
Article Abstract:
Cell adhesion molecules and activation markers, which modulate inflammatory and destructive processes in rheumatoid arthritis, are present in varying levels in rheumatoid nodules and joint synovial tissue. Researchers examined synovium and rheumatoid nodule samples from patients with the autoimmune arthritis. CD4 T-type white blood cells express the PECAM-1, ICAM-1, and VCAM-1 cell adhesion molecules similarly in synovium and rheumatoid nodules, but the nodules have higher levels of E selectin expression, which mobilizes inflammatory cells, than synovium.
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides
Article Abstract:
The measurement of several blood antibodies may improve the diagnosis of rheumatoid arthritis (RA). Researchers tested blood samples from 279 patients with RA and 213 healthy people. Antiperinuclear factor, antikeratin antibodies, or human epidermis filaggrin antibodies were detected in 52% of patients with RA. Detection of antikeratin antibodies and another rheumatoid antibody increased the diagnostic value of the tests. No single antigen could elicit all of the antibodies.
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study
Article Abstract:
The drug infliximab appears to be effective in the treatment of a group of rheumatic diseases called spondyloarthropathies. Infliximab is a monoclonal antibody that blocks the activity of tumor necrosis factor alpha.
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Cytofluorometric analysis of metastases from lung adenocarcinoma with special reference to the difference between hematogenous and lymphatic metastases
- Abstracts: Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients
- Abstracts: A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer. Variability in DNA measurements in multiple tumor samples of human colonic carcinoma
- Abstracts: Serum selenium concentrations in rheumatoid arthritis. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications
- Abstracts: Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected patients. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract